Dr. Thomas Seyfried: Cancer as a Mitochondrial Metabolic Disease

ByCrossFit September 21, 2019

Thomas Seyfried, Ph.D., is a biochemical geneticist, professor of biology at Boston College, and author of the groundbreaking book Cancer as a Metabolic Disease. As part of a lecture delivered on July 31, 2018, at the annual CrossFit Health Conference, Seyfried presented a report card on our current approaches to treating cancer in the United States. Looking at data from the American Cancer Society on cancer incidence and deaths per day between 2013 and 2017, he noted death rates are actually on the rise. “The more money we raise for cancer, the more cancer we get,” he observed. “So you have to ask, ‘What is going on here?’ … This is a failure of monumental proportions.”

The reason for the failure “has to do with a fundamental misunderstanding of what the nature of this disease is,” he explained. “We’ve been led to believe that this is a genetic disease, and I’ll present evidence to say that it’s not.”

The belief that cancer is a genetic disease associated with somatic mutation has become dogma, Seyfried explained, and this dogma shaped much of the cancer research and treatment protocols of the twentieth century. So-called cutting-edge treatments, such as personalized therapy and precision medicine, are based on this viewpoint.

Unfortunately, the viewpoint is wrong, as Seyfried explained in “Cancer as a Mitochondrial Metabolic Disease,” an article published in Frontiers in 2015. There, he aggregated existing research on cancer and reevaluated the information in light of the two competing theories on the origin of the disease (i.e., cancer as a genetic or metabolic disease).

The research he surveyed supported Otto Warburg’s theory that cancer develops as a result of disturbed energy metabolism. Seyfried and his colleagues compared nuclear-cytoplasmic transfer and mitochondrial transfer experiments and found that the mitochondria are “calling the shots, not the nucleus,” which is “the opposite of what we would expect if this were a genetic disease,” he explained.

Seyfried then described what he and his colleagues believe is the missing link in Warburg’s theory. Normal healthy cells derive energy from oxidative phosphorylation. Cancer cells, on the other hand, get energy through fermentation. What Seyfried and his colleagues discovered — and what Warburg did not know — is that cancer cells can ferment not only lactic acid but amino acids as well. That is to say, cancer cells can derive energy for proliferation from glucose and glutamine. Thus, to remove a cancer cell’s energy source, one has to remove its access to fermentable fuels, and an effective way to do this, Seyfried found, is through calorie restriction and ketosis.

Calorie restriction and ketosis, he explained, are anti-angiogenic, anti-inflammatory, and pro-apoptotic. “No cancer drug is known that can do this without toxicity,” he said. He then added that those who claim they don’t understand the mechanism by which calorie restriction and ketosis work are full of “bullshit.” “They don’t read the literature. Nor do they contribute to it,” he said.

Seyfried’s cancer research, particularly on aggressive forms of cancer such as glioblastoma multiforme (GBM) and other stage 4 cancers, led to his development of a glucose-ketone index calculator and the press-pulse therapeutic strategy. The calculator helps patients monitor their progress toward therapeutic ketosis. The press-pulse method pairs press therapies, such as following a keto diet while taking ketone supplements and practicing stress management, with pulse therapies, such as taking glucose and glutamine inhibitors while undergoing hyperbaric oxygen treatments. During his presentation, Seyfried explained how and why these methods are more effective for cancer patients than traditional standard of care.

“GBM and other stage 4 cancers — I don’t consider them as terminal cancers,” he said.

To read a full transcription of the presentation, click here.

Comments on Dr. Thomas Seyfried: Cancer as a Mitochondrial Metabolic Disease


Comment thread URL copied!
Back to 190922
David Whiteside
September 26th, 2019 at 1:58 pm
Commented on: Dr. Thomas Seyfried: Cancer as a Mitochondrial Metabolic Disease

This is a great, digestible overview of the material presented in Dr. Seyfried's groundbreaking book. Among many revelations he mentions in passing that physicians can lose their licenses if they abandon the current grotesque, counterproductive "standard of care" in favor of clearly demonstrated and effective alternative therapies. This sinister, institutionalized protectionism, which may delay important treatments of many diseases for years (generations?) is all about money, not patients. Thanks to Dr. Seyfried for all his work, and for shedding some light on the intransigence of the IRB-s and regulatory agencies which, apparently, exist to suppress or marginalize new ideas.

Comment URL copied!
September 25th, 2019 at 5:44 am
Commented on: Dr. Thomas Seyfried: Cancer as a Mitochondrial Metabolic Disease

I'm very interested in exploring Dr.Seyfied's areas of disagreements with his good friend Dr.D'Agostino, which as I understand it may be in the utility of radiation and chemo (i.e. standard treatments) for certain cancers of the blood and testicles

Both researchers are incredibly insightful and agree on the overall picture of cancer, which is why the areas of disagreement may be where more learning can take place

Comment URL copied!
Joshua Dunn
September 24th, 2019 at 7:28 pm
Commented on: Dr. Thomas Seyfried: Cancer as a Mitochondrial Metabolic Disease

Losing my father to GBM, this presentation made a huge impact on me. When you've seen the destruction, it's more than a topic. It becomes a matter of life and death. Keep fighting the good fight.

Comment URL copied!
September 25th, 2019 at 11:59 pm

Sorry for your loss, Joshua.

Comment URL copied!
Carly Keyes
September 22nd, 2019 at 6:15 pm
Commented on: Dr. Thomas Seyfried: Cancer as a Mitochondrial Metabolic Disease

I can't wait to read his book.

Comment URL copied!